Evidence map›Paper›PMID 37450275›Full record

Trial reportEuropean journal of nutrition2023

Effect of isolated and combined ingestion of caffeine and citrulline malate on resistance exercise and jumping performance: a randomized double-blind placebo-controlled crossover study.

Markus Estifanos Haugen, Fredrik Tonstad Vårvik, Jozo Grgic, Henrik Studsrud, Espen Austheim, Erik Mathias Zimmermann, Hallvard Nygaard Falch, Stian Larsen, Roland van den Tillaar, Thomas Bjørnsen

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in European journal of nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Caffeine's influence on vertical jump height: a real-life collegiate student-athlete approach.Journal of the International Society of Sports Nutrition · 2025
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Markus Estifanos HaugenDepartment of Sport Sciences and Physical Education, Nord University, Levanger, Norway. Haugen@helseogprestasjon.no.ORCID http://orcid.org/0000-0003-0797-664X
Fredrik Tonstad VårvikDepartment of Sport Science and Physical Education, Faculty of Health and Sport Sciences, University of Agder, Kristiansand, Norway.
Jozo GrgicInstitute for Health and Sport, Victoria University, Melbourne, Australia.
Henrik StudsrudDepartment of Sport Sciences and Physical Education, Nord University, Levanger, Norway.
Espen AustheimDepartment of Sport Sciences and Physical Education, Nord University, Levanger, Norway.
Erik Mathias ZimmermannDepartment of Sport Sciences and Physical Education, Nord University, Levanger, Norway.
Hallvard Nygaard FalchDepartment of Sport Sciences and Physical Education, Nord University, Levanger, Norway.
Stian LarsenDepartment of Sport Sciences and Physical Education, Nord University, Levanger, Norway.
Roland van den TillaarDepartment of Sport Sciences and Physical Education, Nord University, Levanger, Norway.
Thomas BjørnsenDepartment of Sport Science and Physical Education, Faculty of Health and Sport Sciences, University of Agder, Kristiansand, Norway.
Nord University · NOUniversity of Agder · NOVictoria University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study was to explore the isolated and combined effects of caffeine and citrulline malate (CitMal) on jumping performance, muscular strength, muscular endurance, and pain perception in resistance-trained participants.

methodsUsing a randomized and double-blind study design, 35 resistance-trained males (n = 18) and females (n = 17) completed four testing sessions following the ingestion of isolated caffeine (5 mg/kg), isolated CitMal (12 g), combined doses of caffeine and CitMal, and placebo. Supplements were ingested 60 min before performing a countermovement jump (CMJ) test (outcomes included jump height, rate of force development, peak force, and peak power), one-repetition maximum (1RM) squat and bench press, and repetitions to muscular failure in the squat and bench press with 60% of 1RM. Pain perception was evaluated following the repetitions to failure tests. The study was registered at ISRCTN (registration number: ISRCTN11694009).

resultsCompared to the placebo condition, isolated caffeine ingestion and co-ingestion of caffeine and CitMal significantly enhanced strength in 1RM bench press (Cohen's d: 0.05-0.06; 2.5-2.7%), muscular endurance in the squat (d: 0.46-0.58; 18.6-18.7%) and bench press (d: 0.48-0.64; 9.3-9.5%). However, there was no significant difference between isolated caffeine ingestion and caffeine co-ingested with CitMal, and isolated CitMal supplementation did not have an ergogenic effect in any outcome. No main effect of condition was found in the analysis for CMJ-derived variables, 1RM squat and pain perception.

conclusionCaffeine ingestion appears to be ergogenic for muscular strength and muscular endurance, while adding CitMal does not seem to further enhance these effects.

Indexed as

Performance-Enhancing SubstancesResistance TrainingCaffeineCitrullineCross-Over StudiesDouble-Blind MethodEatingFemaleHumansMalatesMaleMuscle StrengthPhysical EnduranceCaffeineCitrullinecitrulline malateMalatesPerformance-Enhancing SubstancesBench pressForceHypertrophyNutritional supplementsPowerResistance trainingSports nutritionSquat

Identifiers

PMID37450275
PMCPMC10468939
OpenAlexW4384341002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.